Dr. Ryan Keith Dare, MD

Dr. Dare practices at UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences.

Dr. Dare's NPI, 1922390889, was assigned on May 11, 2011. Dr. Dare graduated from University of Arkansas College of Medicine in 2011. Dr. Dare holds Arkansas license E-9824.

Dr. Dare's primary practice is UAMS Medical Center, at 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 686-5000.

Dr. Dare's primary practice is UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Dr. Dare to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dare practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Dare's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Dare is licensed in Arkansas.

CMS data shows 175 Medicare services from Dr. Dare across 3 procedure codes in 2024, for 104 Medicare patients. Medicare paid $15,127 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 104 Medicare patients who saw Dr. Dare in 2024. The largest group is under 65, with 36 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 40% are also on Medicaid. Their average risk score is 3.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dare's median patient age at 62, with 43% women.

In 2024, Dr. Dare wrote 264 Medicare Part D claims for 34 patients. 35% of them were for generic drugs. CMS names the drug for 149 of them, across 5 drugs with 11 or more claims each, at $454,339 in total drug cost. In 2023, CMS named 252 claims across 9 drugs.

Dr. Dare accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dare as offering telehealth.

Dmand AI links 24 papers to Dr. Dare, published from 2010 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Anti-Bacterial Agents, Blood Culture and COVID-19. Dr. Dare has published most often in Clin Infect Dis. Dr. Dare's most frequent co-authors are Thomas R. Talbot, MD, MPH, George Edward Nelson, MD and Srivani Sanikommu, MD.

Dmand AI links Dr. Dare to 1 clinical trial. Conditions studied include COVID-19 and Pneumonia, Viral.

CMS Open Payments shows 9 general payments to Dr. Dare from 3 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Accelerate Diagnostics Inc. paid the most, $506.

Dr. Dare graduated from University of Arkansas College of Medicine in 2011.